Product Highlight Announcement

Sep 5, 2016 | Events | 0 comments

The 25-OH Vitamin D total ELISA (EIA-5396) was recently awarded the 2015-2016 Certificate of Proficiency by the Vitamin D External Quality Assessment Scheme (DEQAS) Advisory Panel.  This designation certifies that the DRG ELISA meets the performance target set by DEQAS for 25 Hydroxyvitamin D.

DRG-Certificate-2015-2016DRG is committed to bringing to market the best, most accurate tests, and as such, we would like to present the specifications and indications of our 25-OH Vitamin D total ELISA (EIA-5396) testing kit.

Vitamin D deficiency is a serious issue that can affect people at any age.  Without enough sunlight and dietary Vitamin D, children may be at greater risk for rickets and adults may be at greater risk for osteoporosis. While issues in bone development and strength are what first come to mind with Vitamin D deficiency, it has been shown that it may raise the risk of high blood pressure and type 2 diabetes.

Beyond the most commonly studied effects of Vitamin D deficiency, there are a wide-range of other health issues that are currently being researched as being directly impacted by Vitamin D deficiency and lack of absorption, including:

  • Some types of cancer
  • Hypertension (high blood pressure)
  • Schizophrenia
  • Depression
  • Migraines
  • Epilepsy
  • Osteoarthritis
  • Autoimmune conditions (such as lupus, ankylosing spondylitis, multiple sclerosis, rheumatoid arthritis)
  • PCOS (polycystic ovarian syndrome)
  • Diabetes mellitus (both types 1 and 2)
  • Fibromyalgia
  • Osteoporosis/osteopenia

 

DRG offers the 25-OH Vitamin D total ELISA (EIA-5396), approved for laboratory research use only in the United States, and is not for use in diagnostic or therapeutic procedures. However, this product has received its CE Mark.

This DRG Elisa is an enzyme immunoassay for measurement of total 25-OH Vitamin D (Vitamin D2 and Vitamin D3) in serum and plasma.

 

Specifications of the product include:

  • Serum/ Plasma testing
  • Only 25 uL sample required
  • Kit-internal controls
  • Wells single-breakable
  • Very simple assay procedure
  • 105 min incubation time
  • No extraction step required

Gregory C. Guest

Gregory C. Guest

Gregory C. Guest is the International Marketing Manager located at DRG International’s worldwide headquarters in Springfield, NJ.
Gregory C. Guest

News and Updates

Sign Up for Our Newsletter

  • By submitting this form, you are granting: DRG International, Inc., 841 Mountain Avenue, Springfield, NJ, 07081, permission to email you. You may unsubscribe via the link found at the bottom of every email. (See our Email Privacy Policy (http://constantcontact.com/legal/privacy-statement) for details.) Emails are serviced by Constant Contact.

Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.